Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 31, 2024
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
Robbie Marcus Maintained (ATRC) at Buy with Decreased Target to $30 on, Jul 31st, 2024
Robbie Marcus of JP Morgan, Maintained "AtriCure, Inc." (ATRC) at Buy with Decreased Target from $34 to $30 on, Jul 31st, 2024.
Robbie has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Robbie's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robbie
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $49 on, Thursday, May 2nd, 2024
- Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $32 on, Tuesday, April 23rd, 2024
